Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 10,482.6 | 6,577.3 | 3,956.4 | 2,218.2 |
| Revenue growth | 59.4% | 66.2% | 78.4% | |
| Cost of goods sold | 8,709.5 | 6,220.3 | 3,948.6 | 2,418.6 |
| Gross profit | 1,773.1 | 357.0 | 7.7 | -200.4 |
| Gross margin | 16.9% | 5.4% | 0.2% | -9.0% |
| Sales and marketing | 518.2 | 409.2 | 317.4 | 191.7 |
| Research and development | 1,043.8 | 775.1 | 595.2 | 440.5 |
| General and administrative | 601.7 | 379.9 | 238.6 | 146.8 |
| EBITA | -1,740.1 | -1,199.6 | -1,140.7 | -979.4 |
| EBITA margin | -16.6% | -18.2% | -28.8% | -44.2% |
| Amortization of intangibles | 72.3 | 7.7 | 2.9 | |
| EBIT | -1,812.4 | -1,207.3 | -1,143.5 | -979.4 |
| EBIT margin | -17.3% | -18.4% | -28.9% | -44.2% |
| Pre-tax income | -1,576.0 | -947.3 | -1,102.2 | -996.8 |
| Income taxes | 15.7 | 14.9 | 9.0 | 9.6 |
| Net income | -1,588.7 | -982.0 | -1,160.9 | -1,748.9 |
| Net margin | -15.2% | -14.9% | -29.3% | -78.8% |
| |
| Diluted EPS | ($0.46) | ($0.41) | ($1.31) | ($2.20) |
| Shares outstanding (diluted) | 3,441.7 | 2,400.9 | 889.5 | 793.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|